Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Comparison of intensity modulated radiotherapy with simultaneous integrated boost (IMRT-SIB) and a 3-dimensional conformal parotid gland- sparing radiotherapy (ConPas 3D-CRT) in treatment of nasopharyngeal carcinoma: a mono- institutional experience (CROSBI ID 255343)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Bišof, Vesna ; Rakušić, Zoran ; Bibić, Juraj ; Grego, Timor ; Soče, Majana Comparison of intensity modulated radiotherapy with simultaneous integrated boost (IMRT-SIB) and a 3-dimensional conformal parotid gland- sparing radiotherapy (ConPas 3D-CRT) in treatment of nasopharyngeal carcinoma: a mono- institutional experience // Radiologia medica, 123 (2017), 3; 217-226. doi: 10.1007/s11547-017-0824-9

Podaci o odgovornosti

Bišof, Vesna ; Rakušić, Zoran ; Bibić, Juraj ; Grego, Timor ; Soče, Majana

engleski

Comparison of intensity modulated radiotherapy with simultaneous integrated boost (IMRT-SIB) and a 3-dimensional conformal parotid gland- sparing radiotherapy (ConPas 3D-CRT) in treatment of nasopharyngeal carcinoma: a mono- institutional experience

Aim To compare intensity modulated radiotherapy with simultaneous integrated boost (IMRT-SIB) and a 3-dimensional conformal parotid gland-sparing radiotherapy (ConPas 3D-CRT) in treatment of nasopharyngeal carcinoma with regard to outcomes and dose distribution to the planning target volumes (PTVs) and to the organs at risk (OARs). Methods The treatment records of 24 patients with histologically proven carcinoma of the nasopharynx treated with ConPas 3D-CRT or IMRT-SIB technique between May 2009 and December 2016 were assessed. Results The mean dose and dose to 50% parotid glands volume as well as the maximal dose to the spinal cord were signifcantly lower in the IMRT-SIB than in the ConPas 3-CRT group (p < 0.05 ; p < 0.05 ; p < 0.01, respectively). IMRT-SIB was also superior in coverage of PTVs. The 3-year overall survival (OS) and disease-free survival (DFS) of patients in the IMRT-SIB and ConPas 3D-CRT groups were 77 and 81% (p = 0.93), 51.9 and 70.7% (p = 0.83), respectively. Conclusion IMRT-SIB provided additional spearing to parotid glands and spinal cord in comparison to ConPas 3D-CRT technique but without improvement of OS and DFS.

Nasopharyngeal cancer ; Radiotherapy ; Treatment techniques ; Organs at risk

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

123 (3)

2017.

217-226

objavljeno

0033-8362

10.1007/s11547-017-0824-9

Povezanost rada

Fizika, Interdisciplinarne prirodne znanosti, Kliničke medicinske znanosti

Poveznice
Indeksiranost